Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-148209
Filing Date
2016-11-03
Accepted
2016-11-03 16:49:23
Documents
1
Period of Report
2016-11-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6400
  Complete submission text file 0001209191-16-148209.txt   8027
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM 11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM 11 (441) 824-8101
Myovant Sciences Ltd. (Issuer) CIK: 0001679082 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address THURGAUERSTRASSE 130 GLATTPARK-OPFIKON ZURICH V8 8152
Business Address THURGAUERSTRASSE 130 GLATTPARK-OPFIKON ZURICH V8 8152 41-44-555-10-00
Takeda Pharmaceuticals International AG (Reporting) CIK: 0001688140 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 0331
Type: 4 | Act: 34 | File No.: 001-37929 | Film No.: 161972374